Karen C Yeter, Daniel G Arkfeld. Show Affiliations »
Abstract
Entities: Chemical
Mesh: See more » AdalimumabAnti-Bacterial Agents/therapeutic useAnti-Inflammatory Agents/therapeutic useAntibodies, Monoclonal, Humanized/therapeutic useDrug Therapy, CombinationHistiocytosis, Non-Langerhans-Cell/complicationsHistiocytosis, Non-Langerhans-Cell/diagnosisHistiocytosis, Non-Langerhans-Cell/drug therapyHumansImmunosuppressive Agents/therapeutic useMaleMethotrexate/therapeutic useMiddle AgedMinocycline/therapeutic useRemission InductionSkin Diseases/diagnosisSkin Diseases/drug therapySkin Diseases/etiology
Substances: See more » Anti-Bacterial AgentsAnti-Inflammatory AgentsAntibodies, Monoclonal, HumanizedImmunosuppressive AgentsAdalimumabMinocyclineMethotrexate
Year: 2012 PMID: 23441782 DOI: 10.1111/j.1756-185X.2012.01762.x
Source DB: PubMed Journal: Int J Rheum Dis ISSN: 1756-1841 Impact factor: 2.454